BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) completed its acquisition of Amicus Therapeutics for $14.50 per share in an all-cash transaction valued ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions